A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
The much-loved local character, who had lived on the city's streets for decades, died in hospital this week after falling ill.
Man City remain five points behind Chelsea in the Premier League title race after a 1-1 draw at Stamford Bridge
Five NHS trusts in the Midlands have come under fire after it emerged bosses were sitting on more than £134 million of spare cash.